Guillain-Barré syndrome and influenza vaccines: A meta-analysis

Vaccine

Volumn 33, Issue 31, 2015, Pages 3773-3778

  Martin Arias L H ^a   Sanz, R ^a   Sainz M ^a   Treceno C ^a   Carvajal, A ^a  

^a UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Guillain Barr syndrome; Influenza vaccines; Meta analysis

Indexed keywords

INFLUENZA VACCINE;

ARTICLE; AUSTRALIA; EUROPE; GUILLAIN BARRE SYNDROME; HUMAN; INFLUENZA VACCINATION; META ANALYSIS; NORTH AMERICA; PANDEMIC INFLUENZA; PRIORITY JOURNAL; RISK FACTOR; SEASONAL INFLUENZA; SYSTEMATIC REVIEW; TAIWAN; CHEMICALLY INDUCED; GUILLAIN-BARRE SYNDROME; OBSERVATIONAL STUDY;

GUILLAIN-BARRE SYNDROME; INFLUENZA VACCINES; OBSERVATIONAL STUDIES AS TOPIC;

EID: 84937636608     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.05.013     Document Type: Article

References (54)

1. Sejvar J.J., Baughman A.L., Wise M., Morgan O.W. Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology 2011, 36(2):123-133.
2. Shui I.M., Rett M.D., Weintraub E., Marcy M., Amato A.A., Sheikh S.I., et al. Vaccine Safety Datalink Research Team. Guillain-Barré syndrome incidence in a large United States cohort (2000-2009). Neuroepidemiology 2012, 39(2):109-115.
3. Lehmann H.C., Hartung H.-P., Kieseier B.C., Hughes R.A.C. Guillain-Barre syndrome after exposure to influenza virus. Lancet Infect Dis 2010, 10(9):643-651.
4. Tam C.C., O'Brien S.J., Petersen I., Islam A., Hayward A., Rodrigues L.C. Guillain-Barre syndrome and preceding infection with Campylobacter, influenza and Epstein-Barr virus in the General Practice Research Database. PLoS ONE 2007, 2:e344.
5. Stowe J., Andrews N., Wise L., Miller E. Investigation of the temporal association of Guillain-Barre syndrome with influenza vaccine and influenza like illness using the United Kingdom General Practice Research Database. Am J Epidemiol 2009, 169(3):382-388.
6. Tam C.C., O'Brien S.J., Rodrigues L.C. Influenza, Campylobacter and Mycoplasma infections, and hospital admissions for Guillain-Barre syndrome, England. Emerg Infect Dis 2006, 12(12):1880-1887.
7. Tam C.C., Rodrigues L.C., O'Brien S.J. Guillain-Barre syndrome associated with Campylobacter jejuni infection in England, 2000-2001. Clin Infect Dis 2003, 37(2):307-310.
8. Hardy T.A., Blum S., McCombe P.A., Reddel S.W. Guillain-Barr syndrome: modern theories of etiology. Curr Allergy Asthma Rep 2011, 11(3):197-204.
9. Yuki N., Hartung H.P. Guillain-Barre syndrome. N Engl J Med 2012, 366(24):2294-2304.
10. Schonberger L.B., Bregman D.J., Sullivan-Bolyai J.Z., Keenlyside R.A., Ziegler D.W., Retailliau H.F., et al. Guillain-Barré syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol 1979, 110:105-123.
11. Sejvar J.J., Pfeifer D., Schonberger L.B. Guillain-Barré syndrome following influenza vaccination: causal or coincidental?. Curr Infect Dis Rep 2011, 13(4):387-398.
12. Vellozzi C., Burwen D.R., Dobardzic A., Ball R., Walton K., Haber P. Safety of trivalent inactivated influenza vaccines in adults: background for pandemic influenza vaccine safety monitoring. Vaccine 2009, 27(15):2114-2120.
13. Centers for Disease Control Prevention Preliminary results: surveillance for Guillain-Barre syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010. Morb Mortal Wkly Rep 2010, 59:657-661.
14. Hurwitz E., Schonberger L., Nelson D., Holman R. Guillain-Barré syndrome and the 1978-1979 influenza vaccine. N Engl J Med 1981, 304:1557-1561.
15. Kaplan J., Katona P., Hurwitz E., Schonberger L. Guillain-Barré syndrome in the United States, 1979-1980 and 1980-1981. Lack of an association with influenza vaccination. J Am Med Assoc 1982, 248:698-700.
16. Lasky T., Terracciano G.J., Magder L., Koski C.L., Ballesteros M., Nash D., et al. The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med 1998, 339(25):1797-1802.
17. Hughes R.A., Charlton J., Latinovic R., Gulliford M.C. No association between immunization and Guillain-Barré syndrome in the United Kingdom, 1992 to 2000. Arch Intern Med 2006, 166:1301-1304.
18. Juurlink D.N., Stukel T.A., Kwong J., Kopp A., McGeer A., Upshur R.E., et al. Guillain-Barré syndrome after influenza vaccination in adults: a population-based study. Arch Intern Med 2006, 166(20):2217-2221.
19. Burwen D.R., Ball R., Bryan W.W., Izurieta H.S., La Voie L., Gibbs N.A., et al. Evaluation of Guillain-Barré Syndrome among recipients of influenza vaccine in 2000 and 2001. Am J Prev Med 2010, 39(October (4)):296-304.
20. Dieleman J., Romio S., Johansen K., Weibel D., Bonhoeffer J., Sturkenboom M., et al. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. Brit Med J 2011, 343:d3908.
21. Gimaldi-Bensouda L., Alpérovitch A., Besson G., Vial C., Cuisset J.M., Papeix C., et al. Guillain-Barré syndrome, influenzalike illness, and influenza vaccination during seasons with and without circulating A/H1N1 viruses. Am J Epidemiol 2011, 174(3):326-335.
22. Andrews N., Stowe J., Al-Shahi Salman R., Miller E. Guillain-Barré syndrome and H1N1 2009 pandemic influenza vaccination using an AS03 adyuvanted vaccine in the United Kingdom: self-controlled case series. Vaccine 2011, 29:7878-7882.
23. Tokars J.I., Lewis P., DeStefano F., Wise M., Viray M., Morgan O., et al. The risk of Guillain-Barre syndrome associated with influenza A (H1N1) 2009 monovalent vaccine and 2009-2010 seasonal influenza vaccines: results from self-controlled analyses. Pharmacoepidemiol Drug Saf 2012, 21(5):546-552.
24. Yih W.K., Lee G.M., Lieu T.A., Ball R., Kulldorff M., Rett M., et al. Surveillance for adverse events following receipt of pandemic 2009 H1N1 vaccine in the post-licensure rapid immunization safety monitoring (PRISM) system, 2009-2010. Am J Epidemiol 2012, 175(11):1120-1128.
25. Greene S.K., Rett M., Weintraub E.S., Li L., Yin R., Amato A.A., et al. Risk of confirmed Guillain-Barré syndrome following receipt of monovalent inactivated influenza A (H1N1) and seasonal influenza vaccines in the vaccine safety datalink project, 2009-2010. Am J Epidemiol 2012, 175(11):1100-1109.
26. Wise M.E., Viray M., Sejvar J.J., Lewis P., Baughman A.L., Connor W., et al. Guillain-Barré syndrome during 2009-2010 H1N1 influenza vaccination campaign: population-based surveillance among 45 million Americans. Am J Epidemiol 2012, 175(11):1110-1119.
27. De Wals P., Deceuninck G., Toth E., Boulianne N., Brunet D., Boucher R.M., et al. Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec. J Am Med Assoc 2012, 308(2):175-181.
28. Crawford N.W., Cheng A., Andrews N., Charles P.G., Clothier H.J., Day B., et al. Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunization in Victoria: a self-controlled case series. Med J Aust 2012, 197:574-578.
29. Huang W.T., Yang H.W., Liao T.L., Wu W.J., Yang S.E., Chih Y.C., et al. Safety of pandemic (H1N1) 2009 monovalent vaccines in Taiwan: a self-controlled case series study. PLOS ONE 2013, 8(3):e58827.
30. Galeotti F., Massari M., Dalessandro R., Beghi E., Chiò A., Logroscino G., et al. Risk of Guillain-Barré syndrome after 2010-2011 influenza vaccination. Eur J Epidemiol 2013, 28:433-444.
31. Polakowski L.L., Sandhu S.K., Martin D.B., Ball R., MaCurdy T.E., Franks R.L., et al. Chart-confirmed Guillain-Barré syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010. Am J Epidemiol 2013, 178(6):962-973.
32. Baxter R., Bakshi N., Fireman B., Lewis E., Ray P., Vellozi C., et al. Lack of association of Guillain-Barré syndrome with vaccinations. Clin Infect Dis 2013, 57(2):197-204.
33. Kwong J.C., Vasa P.P., Campitelli M.A., Hawken S., Wilson K., Rosella L.C., et al. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis 2013, 13:769-776.
34. Greene S.K., Rett M.D., Vellozi C., Li L., Kulldorff M., Marcy S.M., et al. Guillain-Barré syndrome, influenza vaccination, and antecedent respiratory and gastrointestinal infections: a case-centered analysis in the Vaccine Safety Datalink, 2009-2011. PLOS ONE 2013, 8(6):e67185.
35. McCarthy N.L., Gee J., Lin N.D., Thyagarajan V., Pan Y., Su S., et al. Evaluating the safety of influenza vaccine using a claims-based health system. Vaccine 2013, 31:5975-5982.
36. Romio S., Weibel D., Dieleman J.P., Olberg H.K., de Vries C.S., Sammon C., et al. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe. PLOS ONE 2014, 9(1):e82222.
37. Kawai A.T., Li L., Kulldorff M., Vellozi C., Weintraub E., Baxter R., et al. Absence of associations between influenza vaccines and increased risks of seizures. Guillain-Barré syndrome, encephalitis, or anaphylaxis in the 2012-2013 season. Pharmacoepidemiol Drug Saf 2014, 23:548-553.
38. Vellozi C., Iqbal S., Stewart B., Tokars J., DeStefano F. Cumulative risk of Guillain-Barré syndrome among vaccinated and unvaccinated populations during the 2009 H1N1 influenza pandemic. Am J Public Health 2014, 104:696-701.
39. Prestel J., Volkers P., Mentzer D., Lehmann H.C., Hartung H.P., Keller-Stanislawski B. Risk of Guillain-Barré syndrome following pandemic influenza A (H1N1) 2009 vaccination in Germany. Pharmacoepidemiol Drug Saf 2014, 23(11):1192-1204. GBS Study Group.
40. Dodd C.N., Romio S.A., Black S., Vellozi C., Andrews N., Sturkenboom M., et al. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines. Vaccine 2013, 31:4448-4458.
41. Salmon D.A., Proschan M., Forshee R., Gargiullo P., Bleser W., Burwen D.R., et al. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet 2013, 381(9876):1461-1468.
42. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7(3):177-188.
43. Higgins J.P.T., Green S. Cochrane handbook for systematic reviews of interventions, version 5.0.2 2011, The Cochrane Collaboration.
44. (accessed 17.01.15). http://tech.cochrane.org/revman/download.
45. Liberati A., Altman D.G., Tetzlaff J., Mulrow C., Gøtzsche P.C., Ioannidis J.P.A., et al. The PRISMA statement for reporting systematic reviews and meta-analysis of studies that evaluate health care interventions: explanation and elaboration. Ital J Public Health 2009, 6(4):354-391.
46. McGarvey P.B., Suzek B.E., Baraniuk J.N., Rao S., Conkright B., Lababidi S., et al. In silico analysis of autoimmune diseases and genetic relationships to vaccination against infectious diseases. BMC Immunol 2014, 15(1):61.
47. Blum S., McCombe P.A. Genetics of Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions. J Peripher Nerv Syst 2014, 19(2):88-103.
48. Waddington C.S., Walker W.T., Oeser C., Reiner A., John T., Wilkins S., et al. Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. Br Med J 2010, 340:c2649.
49. Isai A., Durand J., Le Meur S., Hidalgo-Simon A., Kurz X. Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review. Vaccine 2012, 30:7123-7129.
50. Haber P., Sejvar J., Mikaeloff Y., DeStefano F. Vaccines and Guillain-Barré syndrome. Drug Saf 2009, 32(4):309-323.
51. Nachamkin I., Shadomy S.V., Moran A.P., Cox N., Fitzgerald C., Ung H., et al. Anti-ganglioside antibody induction by swine (A/NJ/1976/H1N1) and other influenza vaccines: insights into vaccine-associated Guillain-Barré syndrome. J Infect Dis 2008, 198(2):226-233.
52. Lei T., Siu K.L., Kok K.H., Chan K.H., Chan E.Y., Hung I.F., et al. Anti-ganglioside antibodies were not detected in human subjects infected with or vaccinated against 2009 pandemic influenza A (H1N1) virus. Vaccine 2012, 30(16):2605-2610.
53. Hoshino T., Uchiyama Y., Ito E., Osawa S., Ohashi T. Simultaneous development of acute disseminated encephalomyelitis and Guillain-Barré syndrome associated with H1N1 09 influenza vaccination. Intern Med 2012, 51(12):1595-1598.
54. Whitaker H.J., Paddy Farrington C., Spiessens B., Musonda P. Tutorial in biostatistics: the self-controlled case series method. Stat Med 2006, 25(10):1768-1797.